EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2005. Start Trial.
Date Value
March 31, 2026 -0.9376
December 31, 2025 -1.015
September 30, 2025 -1.069
June 30, 2025 -1.178
March 31, 2025 -1.253
December 31, 2024 -1.339
September 30, 2024 -1.555
June 30, 2024 -1.619
March 31, 2024 -1.588
December 31, 2023 -1.644
September 30, 2023 -1.536
June 30, 2023 -1.627
March 31, 2023 -1.734
December 31, 2022 -1.775
September 30, 2022 -1.915
June 30, 2022 -2.248
March 31, 2022 -2.425
December 31, 2021 -2.365
September 30, 2021 -2.078
June 30, 2021 -1.806
March 31, 2021 -2.143
December 31, 2020 -2.018
September 30, 2020 -2.000
June 30, 2020 -2.203
March 31, 2020 -1.523
Date Value
December 31, 2019 -1.535
September 30, 2019 -4.053
June 30, 2019 -5.043
March 31, 2019 -14.99
December 31, 2018 -22.22
September 30, 2018 -38.71
June 30, 2018 -98.48
March 31, 2018 -96.08
December 31, 2017 -292.58
September 30, 2017 -411.30
June 30, 2017 -562.80
March 31, 2017 -630.00
December 31, 2016 -426.00
September 30, 2016 -288.00
June 30, 2016 -75.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Agenus, Inc. 1.670
Amgen, Inc. 14.38
Halozyme Therapeutics, Inc. 2.780
Protalix Biotherapeutics, Inc. 0.1833
Humacyte, Inc. -0.5747